Why Farbe Firma is the Top Manufacturer of Co Trimoxazole Injection
- Maulik Sudani
- 2 hours ago
- 4 min read
Last Updated: May 19, 2026
TL;DR: Co Trimoxazole Injection — a fixed-dose combination of sulfamethoxazole and trimethoprim — remains a critical broad-spectrum antibacterial for hospitals worldwide. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Co Trimoxazole Injection at our Gujarat, India facility and supplies it to hospitals, tender boards, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Sulfonamide + dihydrofolate reductase inhibitor fixed-dose combination (sulfamethoxazole 400 mg + trimethoprim 80 mg per 5 mL standard); broad-spectrum bactericidal action.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, dedicated antibiotic handling zones.
CTD-ACTD dossier support: Full eCTD / ACTD modules, ICH Q1A stability data, DMF and CEP-style documentation for regulated and emerging markets.
End-to-end CMO services: Contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tender-ready packaging for India, Africa, LATAM, CIS, GCC and Southeast Asia.
Introduction: Why Co Trimoxazole Injection Demands a Premium Manufacturer
Co Trimoxazole Injection is the first-line parenteral therapy for Pneumocystis jirovecii pneumonia in immunocompromised patients, a workhorse in complicated urinary tract infections, and a trusted option in severe gram-negative sepsis when culture sensitivities support it. The combination of sulfamethoxazole and trimethoprim delivers synergistic, sequential blockade of folate synthesis — and that elegant pharmacology only works clinically when the ratio, sterility and stability of each batch are absolutely reliable.
That reliability is harder to engineer than it looks. Sulfamethoxazole has limited aqueous solubility, the combination is sensitive to pH, and intravenous formulations must be filtered to extremely low particulate counts because the patient population is often critically ill. Choosing a Co Trimoxazole Injection manufacturer that treats every batch as a regulated combination product — not just a generic ampoule — is what separates safe parenteral antibiotic supply from a procurement headache.
What Sets a World-Class Co Trimoxazole Injection Manufacturer Apart
A world-class manufacturer of Co Trimoxazole Injection invests in three things competitors often skip: validated combination-product blending, dedicated antibiotic handling zones, and a stability programme that survives real shipping conditions. Blending sulfamethoxazole and trimethoprim in the exact USP/BP/IP-compliant ratio requires qualified mixing equipment, validated dissolution sequences, and in-process HPLC checks at the bulk stage.
Equally important is segregation discipline. Beta-lactam cross-contamination is the obvious risk to manage, but sulfonamides also need careful air-handling, change-over cleaning verification and personnel flow control. World-class plants validate cleaning to a documented limit, swab to specification, and prove via toxicological assessment that residual carry-over is well below clinically meaningful thresholds.
Quality Systems Behind Every Co Trimoxazole Injection
Every Farbe Firma Co Trimoxazole Injection batch is released only after a stack of quality checks: identity by HPLC for both APIs, assay by validated stability-indicating methods, pH, particulate matter by light obscuration, bacterial endotoxin by LAL, and sterility by membrane filtration in dedicated isolators. We follow USP, BP, IP and EP monographs depending on the destination market and supply certificates of analysis that auditors actually find useful.
Behind those release tests sits a deeper layer: validated water-for-injection generation and distribution, qualified HVAC with continuous environmental monitoring, calibrated sterilisation and depyrogenation tunnels, and an electronic batch record system that locks deviations the moment they happen. The result is a Co Trimoxazole Injection supply that performs as expected in every climate zone, with full ICH Q1A long-term and accelerated stability data on file.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Co Trimoxazole Injection Manufacturer for Global Buyers
Farbe Firma Pvt Ltd has built its reputation by treating every injectable with the same regulatory seriousness. We hold WHO-GMP certification, operate from a Gujarat-India facility designed around ISO Class 5 aseptic processing, and have qualified more than 100 sterile injectables for commercial supply. For Co Trimoxazole Injection specifically, we offer the 400 mg + 80 mg per 5 mL ampoule presentation as standard, with custom strengths, fill volumes and pack configurations available under contract manufacturing agreements.
Our CDMO services scale comfortably for hospital tenders, government health-ministry procurements and brand-owner private labels. We support our customers across the registration journey — preparing full CTD or ACTD dossiers, drug master files, stability data per ICH Q1A long-term and accelerated protocols, and translated package inserts for Spanish, French, Portuguese, Russian and Arabic markets.
Buyers also choose Farbe Firma because we are easy to audit and easy to communicate with. Customer auditors are welcomed for plant visits; our quality unit answers technical queries with full data, not marketing language; and our reviewer team includes practising pharmacists and R&D scientists who can speak to formulation choices in detail. For a parenteral antibiotic where patient outcomes hinge on every vial being right, that openness is what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Co Trimoxazole Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Co Trimoxazole Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, qualified water-for-injection systems and validated environmental monitoring. WHO-GMP, USP, BP, IP and EP compliance documentation is available on request.
Which strengths and pack sizes of Co Trimoxazole Injection do you supply?
Our standard presentation is sulfamethoxazole 400 mg + trimethoprim 80 mg per 5 mL ampoule, supplied in cartons typical for hospital tender procurement. Custom strengths, fill volumes, vial-vs-ampoule choices and multi-pack configurations are available under contract manufacturing agreements.
Can Farbe Firma support country-specific registrations for Co Trimoxazole Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability packages (long-term and accelerated), and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. Our regulatory team has supported registrations across 30+ countries in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
How does Farbe Firma prevent cross-contamination during Co Trimoxazole production?
We use validated cleaning procedures with documented residue limits, swab-and-rinse verification, dedicated change-over rooms, controlled personnel flow and segregated HVAC zones. Toxicological assessment supports our cleaning limits, and every campaign change-over is reviewed and approved by Quality Assurance before the next product is loaded.
What is the minimum order quantity for Co Trimoxazole Injection contract manufacturing?
MOQs vary by pack size, label complexity and dossier requirements. For standard ampoule presentations we accommodate hospital-scale and full-tender-scale orders. Contact director@farbefirma.org for a specific quotation against your specification.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments